199 related articles for article (PubMed ID: 17407429)
1. Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia.
Degenhardt L; Roxburgh A; McKetin R
Med J Aust; 2007 Apr; 186(7):342-5. PubMed ID: 17407429
[TBL] [Abstract][Full Text] [Related]
2. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of drug-related hospital separations in Australia.
Roxburgh A; Degenhardt L
Drug Alcohol Depend; 2008 Jan; 92(1-3):149-55. PubMed ID: 17884302
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of methamphetamine use and harm in Australia.
Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
[TBL] [Abstract][Full Text] [Related]
5. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
[TBL] [Abstract][Full Text] [Related]
6. The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
Voce A; McKetin R; Burns R; Castle D; Calabria B
Psychiatry Res; 2018 Jul; 265():19-24. PubMed ID: 29680513
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of psychotic symptoms among methamphetamine users.
McKetin R; McLaren J; Lubman DI; Hides L
Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007.
Roxburgh A; Hall WD; Degenhardt L; McLaren J; Black E; Copeland J; Mattick RP
Addiction; 2010 Jun; 105(6):1071-9. PubMed ID: 20331568
[TBL] [Abstract][Full Text] [Related]
9. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
Ouellet-Plamondon C; Abdel-Baki A; Salvat É; Potvin S
Psychol Med; 2017 Oct; 47(14):2461-2471. PubMed ID: 28424105
[TBL] [Abstract][Full Text] [Related]
10. Substance misuse and early psychosis.
Tucker P
Australas Psychiatry; 2009 Aug; 17(4):291-4. PubMed ID: 19301164
[TBL] [Abstract][Full Text] [Related]
11. Estimating the costs of drug-related hospital separations in Australia.
Riddell S; Shanahan M; Degenhardt L; Roxburgh A
Aust N Z J Public Health; 2008 Apr; 32(2):156-61. PubMed ID: 18412687
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine availability predicts amphetamine-related mental health admissions: A time series analysis.
Sara G; Baxter C; Menendez P; Lappin J
Aust N Z J Psychiatry; 2018 Nov; 52(11):1050-1056. PubMed ID: 29551076
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
[No Abstract] [Full Text] [Related]
14. Results of the Queensland 2007-2012 roadside drug testing program: The prevalence of three illicit drugs.
Davey J; Armstrong K; Martin P
Accid Anal Prev; 2014 Apr; 65():11-7. PubMed ID: 24389088
[TBL] [Abstract][Full Text] [Related]
15. Crystalline methamphetamine use and methamphetamine-related harms in Australia.
Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD
Drug Alcohol Rev; 2017 Mar; 36(2):160-170. PubMed ID: 27286742
[TBL] [Abstract][Full Text] [Related]
16. Does the pattern of amphetamine use prior to incarceration predict later psychosis?--a longitudinal study of amphetamine users in the Swedish criminal justice system.
Rognli EB; Håkansson A; Berge J; Bramness JG
Drug Alcohol Depend; 2014 Oct; 143():219-24. PubMed ID: 25146382
[TBL] [Abstract][Full Text] [Related]
17. Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study.
Schoeler T; Petros N; Di Forti M; Pingault JB; Klamerus E; Foglia E; Small A; Murray R; Bhattacharyya S
JAMA Psychiatry; 2016 Nov; 73(11):1173-1179. PubMed ID: 27680429
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population.
Lappin JM; Roxburgh A; Kaye S; Chalmers J; Sara G; Dobbins T; Burns L; Farrell M
Int J Drug Policy; 2016 Dec; 38():16-20. PubMed ID: 27842249
[TBL] [Abstract][Full Text] [Related]
19. Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: evidence from a prospective cohort study.
Hides L; Chan G; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB
Br J Psychiatry; 2021 Jul; 219(1):361-367. PubMed ID: 31950892
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis.
Lecomte T; Dumais A; Dugré JR; Potvin S
Psychiatry Res; 2018 Oct; 268():189-192. PubMed ID: 30041133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
